Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

Published:2015-10-22 Issue:17 Volume:373 Page:1627-1639
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Borghaei Hossein,Paz-Ares Luis,Horn Leora,Spigel David R.,Steins Martin,Ready Neal E.,Chow Laura Q.,Vokes Everett E.,Felip Enriqueta,Holgado Esther,Barlesi Fabrice,Kohlhäufl Martin,Arrieta Oscar,Burgio Marco Angelo,Fayette Jérôme,Lena Hervé,Poddubskaya Elena,Gerber David E.,Gettinger Scott N.,Rudin Charles M.,Rizvi Naiyer,Crinò Lucio,Blumenschein George R.,Antonia Scott J.,Dorange Cécile,Harbison Christopher T.,Graf Finckenstein Friedrich,Brahmer Julie R.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1507643

Cited by 7980 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Studying protein–protein interactions: Latest and most popular approaches;Journal of Structural Biology;2024-12

2. A Preliminary Study on the Correlation Between TILs and CTCs and Clinical Value in Lung Cancer Patients Analyzed by Lipid Magnetic Microspheres;Science of Advanced Materials;2024-11-01

3. MDM2 inhibitors in cancer immunotherapy: Current status and perspective;Genes & Diseases;2024-11

4. Lung cancer mortality trends and disparities: A cross-sectional analysis 1999–2020;Cancer Epidemiology;2024-10

5. The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer;Translational Research;2024-10